The comparative effects of bariatric surgery on weight and type 2 diabetes
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background: Epidemiological evidence confirms that risk of developing type 2 diabetes is related to weight gain. Weight reduction is beneficial as relative risk is reduced to 0.13 for weight loss >20 kg. This raises the question of effectiveness of bariatric surgery on 1) weight loss and 2) diabetes-related outcomes in morbidly obese patients.
Methods: We reviewed the literature using Medline. Only 2 meta-analyses reporting on both outcomes were included, as well as 50 systematic reviews or primary studies.
Results: Meta-analyses mainly based on case series data as well as controlled studies confirm that bariatric surgery is highly effective in obtaining weight reduction in morbidly obese patients up to 60% of the excess weight, along with resolution of preoperative diabetes in more than 75% of cases. Among bariatric surgery techniques, malabsorptive procedures (biliopancreatic diversion and gastric bypass) appear to be more effective on both outcomes than restrictive procedures (gastroplasty and gastric banding).
Conclusion: Even if more studies are needed to confirm current evidence, bariatric surgery is effective for controlling diabetes. It appears as an efficient strategy from economic modeling due to savings from reduction in diabetes-related costs.
- Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–9. CrossRef
- Mokdad AH, Ford ES, Bowman BA et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care 2000; 23: 1278–83. CrossRef
- Gregg EW, Cadwell BL, Cheng YJ et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 2004; 27: 2806–12. CrossRef
- Fox CS, Pencina MJ, Meigs JB et al. Trends in the incidence of Type 2 diabetes mellitus from the 1970s to the 1990s: The Framingham Heart Study. Circulation 2006; 113: 2914–8. CrossRef
- International Diabetes Federation, Diabetes Atlas — Executive Summary, ed. I.D. Federation. 2003. http://www.eatlas.idf.org/webdata/docs/Atlas%202003-Summary.pdf
- The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care 2003; 26: 61–9. CrossRef
- Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. Also published on http://www.who.int/chp/chronic_disease_report/en.
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782–7. CrossRef
- Caterson ID, Hubbard V, Bray GA et al. Prevention Conference VII: Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Group III: Worldwide Comorbidities of Obesity. Circulation 2004; 110: e476–83. CrossRef
- Malnick SDH and Knobler H. The medical complications of obesity. QJM 2006; 99: 565–79. CrossRef
- Hartemink N, Boshuizen HC, Nagelkerke NJD et al. Combining risk estimates from observational studies with different exposure cutpoints: A meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 2006; 163: 1042–52. CrossRef
- Colditz GA, Willett WC, Rotnitzky A et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–6.
- Chan JM, Rimm EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–9. CrossRef
- Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214–22.
- Koh-Banerjee P, Wang Y, Hu FB et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US Men. Am J Epidemiol 2004; 159: 1150–9. CrossRef
- Hamman RF, Wing RR, Edelstein SL et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29: 2102–7. CrossRef
- Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: iii-iv, 1–182.
- Lean ME, Powrie JK, Anderson AS et al. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990; 7: 228–33. CrossRef
- Rigby N, James P. The obesity campaign view of diabetes prevention. Diabetes Voice 2003; 48: 20–3.
- Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–37. CrossRef
- Maggard MA, Shugarman LR, Suttorp M et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547–59.
- Shekelle PG, Morton SC, Maglione M et al. Pharmacological and surgical treatment of obesity. Evid Rep Technol Assess (Summ) 2004: 1–6.
- Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613–24. CrossRef
- Hall JC, Watts JM, O’Brien PE et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg 1990; 211: 419–27. CrossRef
- Nilsell K, Thorne A, Sjostedt S et al. Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001; 167: 504–9. CrossRef
- Morino M, Toppino M, Bonnet G et al. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 2003; 238: 835–41; discussion 841–2. CrossRef
- Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001; 11: 284–92. CrossRef
- Sjostrom CD, Lissner L, Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477–84.
- Sjostrom CD, Peltonen M, Wedel H et al. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20–5.
- Agren G, Narbro K, Naslund I et al. Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes 2002; 26: 184–92. CrossRef
- Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–93. CrossRef
- Long SD, O’Brien K, MacDonald KG Jr et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 1994; 17: 372–5. CrossRef
- MacDonald KG Jr, Long SD, Swanson MS et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213–20. CrossRef
- Pontiroli AE, Folli F, Paganelli M et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 2005; 28: 2703–9. CrossRef
- Hansen EN, Torquati A, Abumrad NN. Results of bariatric surgery. Annu Rev Nutr 2006; 26: 481–511. CrossRef
- Pories WJ, Flickinger EG, Meelheim D et al. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Ann Surg 1982; 196: 389–99. CrossRef
- Van Rij AM. Gastric bypass and gastric partitioning in morbid obesity: results of a controlled trial. ANZ J Med 1984; 14: 340 (abst).
- Dolan K, Hatzifotis M, Newbury L et al. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004; 14: 165–9. CrossRef
- Thorne A, Lonnqvist F, Apelman J et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes 2002; 26: 193–9. CrossRef
- Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002; 6: 1–153.
- Clegg A, Colquitt J, Sidhu M et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes 2003; 27: 1167–77. CrossRef
- Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg 2005; 200: 270–8. CrossRef
- Narbro K, Agren G, Jonsson E et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes 1999; 23: 619–24. CrossRef
- Gallagher SF, Banasiak M, Gonzalvo JP et al. The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. Obes Surg 2003; 13: 245–8. CrossRef
- Encinosa WE, Bernard DM, Chen CC et al. Healthcare utilization and outcomes after bariatric surgery. Med Care 2006; 44: 706–12. CrossRef
- Martin LF, Tan TL, Horn JR et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995; 118: 599–606; discussion 606–7. CrossRef
- van Gemert WG, Adang EM, Kop M et al. A prospective cost-effectiveness analysis of vertical banded gastroplasty for the treatment of morbid obesity. Obes Surg 1999; 9: 484–91. CrossRef
- Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002; 113: 491–8. CrossRef
- Narbro K, Agren G, Jonsson E et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002; 162: 2061–9. CrossRef
- Potteiger CE, Paragi PR, Inverso NA et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg 2004; 14: 725–30. CrossRef
- Ackroyd R, Mouiel J, Chevallier JM et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg 2006; 16: 1488–503. CrossRef
- Pinkney JH, Sjostrom CD, Gale EA. Should surgeons treat diabetes in severely obese people? Lancet 2001; 357: 1357–9. CrossRef
- Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554–9. CrossRef
- Greenway SE, Greenway FL 3rd, and Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137: 1109–17. CrossRef
- Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes — a systematic review. Diabetes Metab Res Rev 2004; 20: 438–45. CrossRef
- Douketis JD, Macie C, Thabane L et al. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes 2005; 29: 1153–67. CrossRef
- Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462–73. CrossRef
- Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459–61. CrossRef
- The comparative effects of bariatric surgery on weight and type 2 diabetes
Volume 17, Issue 9 , pp 1248-1256
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Bariatric surgery
- type 2 diabetes mellitus
- morbid obesity
- literature review
- treatment outcome
- weight loss
- Industry Sectors
- Author Affiliations
- 1. LEGOS, University of Paris Dauphine, Place du Marechal de Lattre e Tassigny, 75775, PARIS cedex 16, France
- 2. Clinical Center for Minimally Invasive and Bariatric Surgery — ISCARE, and 1st Medical Faculty, Charles University Prague, Prague, Czech Republic
- 3. Department of Endocrinology and Metabolic Diseases, Pisa University Hospital, Pisa, Italy
- 4. Wellcome Trust Clinical Research Facility, Addenbrooke’s Hospital, Cambridge, UK